Advances in Medicine 2022
Hong Kong 28 May 2022 - 29 May 2022
Antibody responses to COVID-19 vaccines in older people: Recent evidence & local data
Older adults have weaker antibody responses to two doses of COVID-19 vaccines [ie, mRNA-based BNT162b2 vaccine and inactivated CZ02 vaccine] vs younger individuals, but a booster dose mounts SARS-CoV-2 neutralization activities to a high level, according to data presented at AIM 2022.
Antibody responses to COVID-19 vaccines in older people: Recent evidence & local data
27 Jun 2022
Can vitamin D prevent severe COVID-19 outcomes in older people?
Vitamin D deficiency is common in modern society, particularly among older people who are homebound. Vitamin D supplements in older people may have a role in preventing serious complications of COVID-19, according to data presented at AIM 2022.
Can vitamin D prevent severe COVID-19 outcomes in older people?
22 Jun 2022
How effective were oral antivirals during HK’s Omicron BA.2 wave?
A real-world study during Hong Kong’s Omicron BA.2 wave showed that both molnupiravir and nirmatrelvir/ritonavir effectively lowered the risks of disease progression and all-cause mortality in hospitalized COVID-19 patients not requiring oxygen supplementation on admission. However, mortality risk reduction was larger with nirmatrelvir/ritonavir vs molnupiravir.